Key result
PKCδ-null mice developed significantly more severe vein graft arteriosclerosis compared to wild-type mice (P < 0.01), associated with decreased smooth muscle cell apoptosis.
p-value: p=<0.01
PKCδ may limit vein graft arteriosclerosis in mice; leaves open its therapeutic targeting in human bypass patients.
1a) using the standard techniques of the
No takes yet. Share an insight, caveat, or question.
Leitges et al. (2001) studied Vein graft arteriosclerosis (n=24). PKCδ knockout vs. Wild-type (PKCδ+/+) was evaluated on Neointimal lesion area at 8 weeks (p=<0.01). PKCδ-null mice developed significantly more severe vein graft arteriosclerosis compared to wild-type mice (P < 0.01), associated with decreased smooth muscle cell apoptosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: